Ballentine Partners’s CureVac CVAC Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $205K | Buy |
37,804
+6,231
| +20% | +$33.8K | ﹤0.01% | 874 |
|
|
2025
Q1 | $87.5K | Buy |
31,573
+14,210
| +82% | +$39.4K | ﹤0.01% | 862 |
|
|
2024
Q4 | $58.6K | Sell |
17,363
-5,392
| -24% | -$18.2K | ﹤0.01% | 867 |
|
|
2024
Q3 | $66.9K | Buy |
22,755
+8,406
| +59% | +$24.7K | ﹤0.01% | 817 |
|
|
2024
Q2 | $48.8K | Buy |
14,349
+1,752
| +14% | +$5.96K | ﹤0.01% | 745 |
|
|
2024
Q1 | $38.2K | Buy |
+12,597
| New | +$38.2K | ﹤0.01% | 731 |
|